NCT05294328: Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia
- State
- Completed
- Phase
- Phase 2
- People
- 68 taking part
- Started
- 5 May 2022
- Primary completion
- 22 Aug 2022
- Arms
- Vehicle Ophthalmic Solution dosed bilaterally
- Results
- Posted on the registry
- 24 Mar 2022: Trial registered
- 5 May 2022: Trial started
- 10 Sep 2022: Trial completed
- 5 Sep 2024: Trial results posted